Evidence map›Paper›PMID 26261989›Full record

ArticlePloS one2015

Microbial Ligand Costimulation Drives Neutrophilic Steroid-Refractory Asthma.

Sabelo Hadebe, Frank Kirstein, Kaat Fierens, Kong Chen, Rebecca A Drummond, Simon Vautier, Sara Sajaniemi, Graeme Murray, David L Williams, Pierre Redelinghuys and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. MelLec Exacerbates the Pathogenesis ofFrontiers in immunology · 2021
    Article
  10. Article
  11. Review
  12. How a farming environment protects from atopy.Current opinion in immunology · 2019
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Non-eosinophilic asthma: current perspectives.Journal of asthma and allergy · 2018
    Review
  18. C-Type Lectin Receptors in Asthma.Frontiers in immunology · 2018
    Review
  19. Review
  20. Myeloid Cells in Asthma.Microbiology spectrum · 2017
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 5 countries.

Sabelo HadebeAberdeen Fungal Group, Infection, Immunity and Inflammation Programme, University of Aberdeen, United Kingdom. Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, South Africa.
Frank KirsteinInternational Centre for Genetic Engineering and Biotechnology and Division of Immunology, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, South Africa.
Kaat FierensVIB Inflammation Research Center, Laboratory of Immunoregulation and Mucosal Immunology, University Ghent, Ghent, Belgium.
Kong ChenDepartment of Paediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Rebecca A DrummondAberdeen Fungal Group, Infection, Immunity and Inflammation Programme, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, South Africa.
Simon VautierAberdeen Fungal Group, Infection, Immunity and Inflammation Programme, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, South Africa.
Sara SajaniemiAberdeen Fungal Group, Infection, Immunity and Inflammation Programme, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, South Africa.
Graeme MurrayPathology, Division of Applied Medicine, Institute of Medical Sciences, Foresterhill, University of Aberdeen, Aberdeen, United Kingdom.
David L WilliamsDepartment of Surgery and Center for Inflammation, Infectious Disease and Immunity, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee, United States of America.
Pierre RedelinghuysAberdeen Fungal Group, Infection, Immunity and Inflammation Programme, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, South Africa.
Todd A ReinhartDepartment of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Beth A Fallert JuneckoDepartment of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Jay K KollsDepartment of Paediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Bart N LambrechtVIB Inflammation Research Center, Laboratory of Immunoregulation and Mucosal Immunology, University Ghent, Ghent, Belgium; Department of Pulmonary Medicine, ErasmusMC, Rotterdam, The Netherlands.
Frank BrombacherInternational Centre for Genetic Engineering and Biotechnology and Division of Immunology, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, South Africa.
Gordon D BrownAberdeen Fungal Group, Infection, Immunity and Inflammation Programme, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Science, University of Cape Town, South Africa.
University of Cape Town · ZAUniversity of Pittsburgh · USEast Tennessee State University · USErasmus MC · NLUniversity of Aberdeen · GBVIB-UGent Center for Inflammation Research · BE

Funding

Innate Immunity and Cardiovascular Function in SepsisR01GM083016 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI LI, CHUANFU, WILLIAMS, DAVID L. · 2009 to 2021
$3.8M
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATIONR01GM053522 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI WILLIAMS, DAVID L. · 1996 to 2015
$3.4M
NIGMS NIH HHS GM083016NIGMS NIH HHS GM53522NIGMS NIH HHS R01 GM053522NIGMS NIH HHS R01 GM083016Wellcome Trust 102705Wellcome Trust 102705/Z/13/Z
6 · The paper itself

Abstract

Asthma is a heterogeneous disease whose etiology is poorly understood but is likely to involve innate responses to inhaled microbial components that are found in allergens. The influence of these components on pulmonary inflammation has been largely studied in the context of individual agonists, despite knowledge that they can have synergistic effects when used in combination. Here we have explored the effects of LPS and β-glucan, two commonly-encountered microbial agonists, on the pathogenesis of allergic and non-allergic respiratory responses to house dust mite allergen. Notably, sensitization with these microbial components in combination acted synergistically to promote robust neutrophilic inflammation, which involved both Dectin-1 and TLR-4. This pulmonary neutrophilic inflammation was corticosteroid-refractory, resembling that found in patients with severe asthma. Thus our results provide key new insights into how microbial components influence the development of respiratory pathology.

Indexed as

AnimalsAsthmabeta-GlucansDisease Models, AnimalDrug ResistanceInflammationLipopolysaccharidesMice, KnockoutNeutrophil InfiltrationNeutrophilsPyroglyphidaeSteroidsTh17 CellsTh2 Cellsbeta-GlucansLipopolysaccharidesSteroids

Identifiers

PMID26261989
PMCPMC4532492
OpenAlexW1913037015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.